Literature DB >> 8633627

Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia.

S T Davidge1, C P Stranko, J M Roberts.   

Abstract

OBJECTIVE: Nitric oxide is a potent vasorelaxant produced by endothelial cells. We tested the hypothesis that urinary and perhaps plasma nitric oxide metabolites would be reduced in women with preeclampsia. STUDY
DESIGN: Plasma and urine from 14 women meeting strict clinical criteria for the diagnosis of preeclampsia and 20 normal nulliparous women were assayed for the stable metabolites of nitric oxide, nitrate and nitrite. RESULT: There was no significant difference of plasma concentrations of nitrate and nitrite between women with preeclampsia and women with normal pregnancies (32.7 +/- 3.1 vs 25.8 +/- 2.4 micromol/L). Plasma creatinine levels were elevated in women with preeclampsia (0.85 +/- 0.09 vs 0.66 +/- 0.02 mg/dl, p<0.01), indicating a reduced glomerular filtration rate. Urine concentrations of nitrate and nitrite normalized by creatinine excretion were significantly lower in women with preeclampsia compared with normal pregnant women (0.37 +/- 0.06 vs 0.69 +/- 0.11 micromol of nitrite per milligram creatinine, p. <0.05).
CONCLUSIONS: Our study using concomitant measurement of plasma and urine nitrate and nitrite suggests a reduced production of nitric oxide in women with preeclampsia compared with normal pregnant women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633627     DOI: 10.1016/s0002-9378(96)70341-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

Review 1.  The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials.

Authors:  T Dorniak-Wall; R M Grivell; G A Dekker; W Hague; J M Dodd
Journal:  J Hum Hypertens       Date:  2013-10-31       Impact factor: 3.012

Review 2.  PPAR-γ -- a possible drug target for complicated pregnancies.

Authors:  Fergus P McCarthy; Aoife C Delany; Louise C Kenny; Sarah K Walsh
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 3.  Gap junction regulation of vascular tone: implications of modulatory intercellular communication during gestation.

Authors:  Bryan C Ampey; Timothy J Morschauser; Paul D Lampe; Ronald R Magness
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

5.  The role of neutrophil activation in pathogenesis of preeclampsia.

Authors:  H Chen; Z Wang; M Lin
Journal:  J Tongji Med Univ       Date:  2000

6.  Local effects of pregnancy on connexin proteins that mediate Ca2+-associated uterine endothelial NO synthesis.

Authors:  Timothy J Morschauser; Jayanth Ramadoss; Jill M Koch; Fu Xian Yi; Gladys E Lopez; Ian M Bird; Ronald R Magness
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

Review 7.  Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology.

Authors:  A C Palei; F T Spradley; J P Warrington; E M George; J P Granger
Journal:  Acta Physiol (Oxf)       Date:  2013-05-07       Impact factor: 6.311

Review 8.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

Review 9.  Nitric oxide for preventing pre-eclampsia and its complications.

Authors:  S Meher; L Duley
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

10.  Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial.

Authors:  Thomas P Walsh; Grayson L Baird; Michael K Atalay; Saurabh Agarwal; Daniel Arcuri; James R Klinger; Christopher J Mullin; Heather Morreo; Brynn Normandin; Sruti Shiva; Mary Whittenhall; Corey E Ventetuolo
Journal:  Pulm Circ       Date:  2021-05-21       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.